Advertisement

Advances in Therapy

, 25:703 | Cite as

The schizophrenia and Toxoplasma gondii connection: Infectious, immune or both?

  • Gulden Sonmez TamerEmail author
  • Devrim Dundar
  • Irem Yalug
  • Seyda Caliskan
  • Suleyman Yazar
  • Ahmet Aker
Original Research

Abstract

Introduction

Recent research has suggested a possible link between toxoplasmic agents and schizophrenia. We aimed to assess this by measuring Toxoplasma gondii-associated antibodies in schizophrenia patients and controls

Methods

We used a commercially available enzyme-linked immunosorbent assay (ELISA) kit to measure the level of immunoglobulin G (IgG) and IgM antibodies in serum samples from schizophrenia patients (n=40) and from a group of non-schizophrenic control subjects (n=37)

Results

Among schizophrenic patients, 16 (40%) showed IgG seropositivity and two (5%) showed IgM seropositivity. Among the control group, five (13.5%) were found have IgG seropositivity and one (2.7%) showed IgM seropositivity. In our study we found that IgG T gondii antibodies were significantly higher in schizophrenia patients compared with controls

Conclusions

This study supports the theory that toxoplasmic agents may have a role in the aetiology of schizophrenia

Keywords

enzyme immunoassay schizophrenia Toxoplasma gondii 

References

  1. 1.
    Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Bernstein D, Yolken RH. Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry. 2001;58:1032–1037.PubMedCrossRefGoogle Scholar
  2. 2.
    Leweke FM, Gerth CW, Koethe D, et al. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2004;254:4–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Susser E, Hoaek HW, Brown A. Neurodevelopmental disorders after prenatal famine: the story of the Dutch Famine Study. Am J Epidemiol. 1998;147:213–216.PubMedGoogle Scholar
  4. 4.
    Mortensen PB, Nørgaard-Pedersen B, Waltoft BL, Sørensen TL, Hougaard D, Yolken RH. Early infections of Toxoplasma gondii and the later development of schizophrenia. Schizophr Bull. 2007;33:741–744.PubMedCrossRefGoogle Scholar
  5. 5.
    Flegr J, Preiss M, Klose J, Havlicek J, Vitakova M, Kodym P. Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii dopamine, a missing link between schizophrenia and toxoplasmosis? Biol Psychol. 2003;63:253–268.PubMedCrossRefGoogle Scholar
  6. 6.
    Amminger GP, McGorry PD, Berger GE, et al. Antibodies to infectious agents in individuals at ultra-high risk for psychosis. Biol Psychiatry. 2007;61:1215–1217.PubMedCrossRefGoogle Scholar
  7. 7.
    Brown AS, Schaefer CA, Quesenberry CP, Liu L, Babulas VP, Susser ES. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry. 2005;162:767–773.PubMedCrossRefGoogle Scholar
  8. 8.
    Jackson MH, Hutchinson WM. The prevelance and source of Toxoplasma infection in the environment. Adv Parasitol. 1989;28:55–105.PubMedCrossRefGoogle Scholar
  9. 9.
    Bachmann S, Schröder J, Bottmer C, Torrey EF, Yolken RH. Psychopathology in first-episode schizophrenia and antibodies to Toxoplasma gondii. Psychopathology. 2005;38:87–90.PubMedCrossRefGoogle Scholar
  10. 10.
    Skallova A, Kodym P, Frynta D, Flegr J. The role of dopamine in Toxoplasma-induced behavioral alterations in mice: an ethological and ethopharmacological study. Parasitology. 2006;2:1–11.Google Scholar
  11. 11.
    First M, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis 1 Disorders (SCID-1), Clinical Version. Washington DC: American Psychiatric Publishing, Inc; 1977.Google Scholar
  12. 12.
    Niebuhr DW, Millikan AM, Cowan DN, Yolken R, Li Y, Weber NS. Selected infectious agents and risk of schizophrenia among U.S. military personnel. Am J Psychiatry. 2008;165:99–106PubMedCrossRefGoogle Scholar
  13. 13.
    Li Q, Luo XL. Controlled study of schizophrenia and affective disorders and Toxoplasma infection. Acta Acad Med Hubei. 1999;20:223–225.Google Scholar
  14. 14.
    Yolken RH, Bachmann S, Rouslanova I, et al. Antibodies Toxoplasma gondii in individuals with first-episode schizophrenia. Clin Infect Dis. 2001;32:842–844.PubMedCrossRefGoogle Scholar
  15. 15.
    Torrey EF, Yolken RH. Could schizophrenia be a viral zoonosis transmitted from house cats? Schizophr Bull. 1995;21:167–171.PubMedGoogle Scholar
  16. 16.
    Torrey EF, Rawlings R, Yolken RH. The antecedents of psychoses: a case control study of selected risk factors. Schizophr Res. 2000;46:17–23.CrossRefGoogle Scholar
  17. 17.
    Holliman RE. Toxoplasmosis, behavior and personality. J Infect. 1997;35:105–110.PubMedCrossRefGoogle Scholar
  18. 18.
    Ledgerwood LG, Ewald PW, Cochran GM. Genes, germs and schizophrenia an evolutionary perspective. Perspect Biol Med. 2003;46:317–348.PubMedCrossRefGoogle Scholar
  19. 19.
    Flegr J, Hrdy I. Influence of chronic toxoplasmosis on some human personality factors. Folia Parasitol (Praha). 1994;41:122–126.Google Scholar
  20. 20.
    Jones-Brando L, Torrey EF, Yolken R. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res. 2003;62:237–244.PubMedCrossRefGoogle Scholar
  21. 21.
    Conejero-Goldberg C, Torrey EF, Yolken RH. Herpesviruses and Toxoplasma gondii in orbital frontal cortex of psychiatric patients. Schizophr Res. 2003;60:65–69.PubMedCrossRefGoogle Scholar
  22. 22.
    Selten JP, Kahn RS. Schizophrenia after prenatal exposure to Toxoplasma gondii? Clin Infect Dis. 2002;35:633–634.PubMedCrossRefGoogle Scholar
  23. 23.
    Torrey EF, Yolken RH. Schizophrenia and toxoplasmosis. Schizophr Bull. 2007;33:727–728.PubMedCrossRefGoogle Scholar
  24. 24.
    Zhu S, Guo MF, Feng QC, Fan JM, Zhang LX. Epidemiological evidences from China assume that psychiatric-related diseases may be associated with Toxoplasma gondii infection. Neuro Endocrinol Lett. 2007;28:115–120.PubMedCrossRefGoogle Scholar
  25. 25.
    Cetinkaya Z, Yazar S, Gecici O, Namli MN. Anti-Toxoplasma gondii antibodies in patients with schizophrenia — preliminary findings in a Turkish sample. Schizophr Bull. 2007;33:789–791.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Healthcare Communications 2008

Authors and Affiliations

  • Gulden Sonmez Tamer
    • 1
    • 4
    Email author
  • Devrim Dundar
    • 1
  • Irem Yalug
    • 2
  • Seyda Caliskan
    • 1
  • Suleyman Yazar
    • 3
  • Ahmet Aker
    • 2
  1. 1.Department of Clinical MicrobiologyKocaeli University, Medical FacultyKocaeliTurkey
  2. 2.Department of PsychiatryKocaeli University, Medical FacultyKocaeliTurkey
  3. 3.Department of ParasitologyErciyes University, Medical FacultyKayseriTurkey
  4. 4.Klinik Mikrobiyoloji Anabilim DaliKocaeli Universitesi Tip Fakültesi Umuttepe Kampüsü KocaeliTürkiye

Personalised recommendations